Story perspectives

Fecal Transplants Boost Survival in Critical C. Difficile Cases

4/9/2026

Summary

Story summary

On April 6, 2026, University of Minnesota researchers reported that fecal transplants improved survival for critically ill patients with C. difficile infections, with 12 of 18 survived after a year.
They observed inflammation markers and noted that delaying antibiotics beyond four days after transplant risks relapse.
They urged treatment and hospital maintenance of a fecal microbiota bank for timely interventions, and called for larger studies to validate this option.

1 of 1

Story summary

On April 6, 2026, University of Minnesota researchers reported that fecal transplants improved survival for critically ill patients with C. difficile infections, with 12 of 18 survived after a year.
They observed inflammation markers and noted that delaying antibiotics beyond four days after transplant risks relapse.
They urged treatment and hospital maintenance of a fecal microbiota bank for timely interventions, and called for larger studies to validate this option.